Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Matthew David Ringel
Introduction
Matthew David Ringel is a notable inventor based in Columbus, OH. He has made significant contributions to the field of cancer research through his innovative work on anticancer compounds. His dedication to advancing medical science is evident in his patented inventions.
Latest Patents
Matthew David Ringel holds a patent for "Anticancer P21-activated kinase inhibitors." This patent describes compounds according to a specific formula, wherein Ar is a fused aryl group, and R is selected from alkyl and aryl amides, CF, and CHOH. The compounds are effective for inhibiting p21-activated kinases and can be utilized for the prevention and treatment of cancer. He has 1 patent to his name, showcasing his commitment to developing effective cancer therapies.
Career Highlights
Ringel is associated with the Ohio State Innovation Foundation, where he continues to work on groundbreaking research. His role at this institution allows him to collaborate with other experts in the field and contribute to innovative solutions for cancer treatment.
Collaborations
Some of his notable coworkers include Ching-Shih Chen and Motoyashi Saji. Their collaborative efforts enhance the research environment and foster innovation in cancer therapies.
Conclusion
Matthew David Ringel's work exemplifies the spirit of innovation in the medical field. His contributions to anticancer research are paving the way for new treatment options, demonstrating the importance of dedicated inventors in advancing healthcare.